RobertAlanHromasMDFACP
Hematology • San Antonio, TXHematologic Oncology
Dean, Long School of Medicine, UT Health San Antonio
Dr. Hromas is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
7979 Wurzbach Road
San Antonio, TX 78229Phone+1 210-450-1143Fax+1 210-450-0407
Summary
- Dr. Robert Hromas is a hematologist in San Antonio, TX and is affiliated with multiple hospitals in the area, including University Health / UT Health Science Center at San Antonio and University Health / UT Health Science Center at San Antonio. He received his medical degree from McGovern Medical School at UTHealth and has been in practice 35 years. He specializes in hematologic oncology. He has more than 200 publications and over 10,000 citations.
Education & Training
University of WashingtonFellowship, Hematology, 1988 - 1990
University of Iowa Hospitals and ClinicsResidency, Internal Medicine, 1984 - 1988
University of Iowa (Des Moines)Internship, Internal Medicine, 1984 - 1985
McGovern Medical School at UTHealthClass of 1984
Certifications & Licensure
TX State Medical License 2018 - 2026
FL State Medical License 2011 - 2019
NM State Medical License 2003 - 2011
WA State Medical License 1988 - 1991
IA State Medical License 1984 - 1990- American Board of Internal Medicine Internal Medicine
Publications & Presentations
PubMed
- Phase II Trial of the PARP Inhibitor, Niraparib, in BAP1 and Other DNA Damage Response Pathway-Deficient Neoplasms.Thomas J George, Ji-Hyun Lee, David L DeRemer, Peter J Hosein, Steven Staal
JCO Precision Oncology. 2024-12-01 - Colibactin Exerts Androgen-dependent and -independent Effects on Prostate Cancer.Raag Agrawal, Sarah Al-Hiyari, Rupert Hugh-White, Robert Hromas, Yash Patel
European Urology Oncology. 2024-11-14 - MiR-223-3p promotes genomic stability of hematopoietic progenitors after radiation.Shi Chen, Gayathri Srinivasan, Aruna Jaiswal, Elizabeth A Williamson, Lingxiao Li
Experimental Hematology. 2024-01-01
Press Mentions
SA’s $472M Cancer Research Hospital Set to OpenNovember 13th, 2024- New San Antonio Hospital Seen as a ‘Place of Firsts’ in Treatment, Training and ResearchNovember 11th, 2024
- UT Health San Antonio World-Renowned Expert in BRCA Research to Be Honored for Global ContributionsOctober 21st, 2024
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
